Top

Losartan Recall Lawsuit

In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). This is the third blood pressure drug to have been recalled due to possible cancer risk.

Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. However, these Losartan users are still at risk for contamination. Did you or a loved one contract cancer after taking a “Sartan” blood pressure medication drug? Contact our experienced drug recall lawyers for a free consultation.

Losartan Recall Lawsuit: Case Quick Facts

The Problem: Losartan and Cancer

Losartan is indicated for the treatment of hypertension. The brand name, Cozaar, was approved by the FDA in 1995 and the generic, Losartan, was approved in April 2010. The recall involves one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. It was recalled due to the trace amount of N-nitrosodiethylamine (NDEA), an impurity that has been classified as a probable human carcinogen by the International Agency for Research on Cancer.

Which Losartan Pills were Recalled?

  • Losartan Potassium Hydrochlorothiazide
  • 100mg/25mg tablets in 1000-count plastic bottles
  • NDC 0781-5207-10
  • Lot number JB8912
  • Expiration date 06/2020
The Injuries: Side Effects of Losartan

According to the Environmental Protection Agency, NDEA exposure can lead to:

  • Liver cancer
  • Kidney cancer
  • Stomach cancer
  • Intestinal/colon/colorectal cancer
  • Pancreatic cancer
The Defendant(s)

The recalled Losartan was manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd. This is the same company involved in the NDMA contamination of Valsartan.

GoldenbergLaw Can Help

If you or a loved one took Losartan and was diagnosed with liver, kidney, pancreatic, stomach, or colorectal cancer, contact us.

Do I Qualify?

Free Consultations

Contact GoldenbergLaw today for a free consultation. Our consultations cost you nothing, including an obligation. The only time you’ll get a fee from us is if we win your case. Get your free consultation today and get started on your path towards justice and compensation.

Contact Us Call 800-903-1643

FDA Losartan Recall – November 8, 2018

The FDA issued a recall for Losartan. The lot was allegedly contaminated with NDEA, a substance that is a probable human carcinogen. Losartan is the most recent recall in a series of blood pressure medication recalls by the FDA.

Why Choose GoldenbergLaw?

We treat our clients like family. This means we establish an open line of communication, honest representation, and unwavering dedication. We want to make sure you get the care and compensation you deserve.

Compassion and Respect for Clients

Focused on Client-Centered Solutions

Open and Honest Representation

Meet Your Losartan Recall Team

Attorney Referral

Have a potential client we could help?

Referral Form

Free Consultation

Call us. You’ll sleep better.

Schedule Now